{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=108", "query": { "intervention": "Age", "page": 108 }, "page_size": 10 }, "pagination": { "page": 108, "page_size": 10, "total_count": 8279, "total_pages": 828, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=109&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=107&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T06:24:41.943Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01505569", "title": "Auto Transplant for High Risk or Relapsed Solid or CNS Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ewing's Family Tumors", "Renal Tumors", "Hepatoblastoma", "Rhabdomyosarcoma", "Soft Tissue Sarcoma", "Primary Malignant Brain Neoplasms", "Retinoblastoma", "Medulloblastoma", "Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)", "Atypical Teratoid/Rhabdoid Tumor (AT/RT)", "CNS Tumors", "Germ Cell Tumors" ], "interventions": [ { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" }, { "name": "G-CSF", "type": "BIOLOGICAL" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" }, { "name": "Autologous stem cell infusion", "type": "BIOLOGICAL" }, { "name": "Radiation", "type": "RADIATION" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Leukapheresis", "type": "PROCEDURE" }, { "name": "Anti-seizure prophylaxis", "type": "DRUG" }, { "name": "Ursodiol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "RADIATION", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "70 Years", "sex": "ALL", "summary": "Up to 70 Years" }, "enrollment_count": 44, "start_date": "2011-10-20", "completion_date": "2024-02-01", "has_results": false, "last_update_posted_date": "2024-02-26", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01505569" }, { "nct_id": "NCT04218851", "title": "Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Invasive Aspergillosis" ], "interventions": [ { "name": "Posaconazole IV", "type": "DRUG" }, { "name": "Posaconazole PFS", "type": "DRUG" }, { "name": "Posaconazole tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 31, "start_date": "2020-07-02", "completion_date": "2023-12-18", "has_results": true, "last_update_posted_date": "2025-01-14", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 4, "location_summary": "Orange, California • San Diego, California • Chicago, Illinois + 1 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04218851" }, { "nct_id": "NCT00046059", "title": "Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ADHD" ], "interventions": [], "intervention_types": [], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "7 Years to 110 Years" }, "enrollment_count": 3481, "start_date": "2000-02-08", "completion_date": "2020-01-24", "has_results": false, "last_update_posted_date": "2024-12-24", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 2, "location_summary": "Orange, California • Bethesda, Maryland", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00046059" }, { "nct_id": "NCT07227727", "title": "Endothelial Dysfunction After SCI", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinal Cord Injuries", "Endothelial Dysfunction" ], "interventions": [ { "name": "Intra-arterial Infusion of Vasoactive Agents", "type": "PROCEDURE" }, { "name": "Intra-arterial Vitamin C Infusion", "type": "PROCEDURE" }, { "name": "Blood Sampling", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Craig Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2025-07-31", "completion_date": "2027-07-30", "has_results": false, "last_update_posted_date": "2025-11-14", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 1, "location_summary": "Englewood, Colorado", "locations": [ { "city": "Englewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227727" }, { "nct_id": "NCT05128942", "title": "A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Congenital Adrenal Hyperplasia", "21-OHD" ], "interventions": [ { "name": "Tildacerfont", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spruce Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 67, "start_date": "2021-12-10", "completion_date": "2025-01-31", "has_results": true, "last_update_posted_date": "2025-12-24", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 13, "location_summary": "Sacramento, California • San Diego, California • Chicago, Illinois + 10 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05128942" }, { "nct_id": "NCT07780669", "title": "A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "GSK5784283", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 624, "start_date": "2026-08-27", "completion_date": "2030-03-15", "has_results": false, "last_update_posted_date": "2026-11-12", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 7, "location_summary": "Doral, Florida • Derby, Kansas • Lake Charles, Louisiana + 4 more", "locations": [ { "city": "Doral", "state": "Florida" }, { "city": "Derby", "state": "Kansas" }, { "city": "Lake Charles", "state": "Louisiana" }, { "city": "Staten Island", "state": "New York" }, { "city": "Humble", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07780669" }, { "nct_id": "NCT04673994", "title": "Blood Flow Response and Acute INterval Exercise", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke", "High Intensity Interval Exercise" ], "interventions": [ { "name": "Single, acute bout of high intensity interval exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 91, "start_date": "2020-12-09", "completion_date": "2023-02-03", "has_results": false, "last_update_posted_date": "2023-02-09", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04673994" }, { "nct_id": "NCT07600866", "title": "Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan Cohort", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sarcopenia", "Body Composition", "Obesity" ], "interventions": [ { "name": "Soma Body-Composition Segmentation Software", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Nucleo Research, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2026-05-31", "completion_date": "2026-06-15", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07600866" }, { "nct_id": "NCT02286089", "title": "Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Age-Related Macular Degeneration" ], "interventions": [ { "name": "OpRegen", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 24, "start_date": "2015-04-01", "completion_date": "2031-01-31", "has_results": true, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 3, "location_summary": "San Francisco, California • Cincinnati, Ohio • Philadelphia, Pennsylvania", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02286089" }, { "nct_id": "NCT00384397", "title": "A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "249 Days", "maximum_age": "305 Days", "sex": "ALL", "summary": "249 Days to 305 Days" }, "enrollment_count": 1128, "start_date": "2006-09", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-11-15T06:24:41.943Z", "location_count": 39, "location_summary": "Montgomery, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 35 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384397" } ] }